AzTrials
AzTrials

Anesthesia Intubation ComplicationLA-STEROIDNCT04085744

A Comparison Of Local Anesthetic Agents And Steroid On Tracheal Tube Cuff

A study testing Lidocaine 10% Spray and Mometasone nasal spray in people with Anesthesia Intubation Complication and Intubation Complication, run by Derince Training and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to compare effects of two different agents on complications due to tracheal tube cuff in pediatric patients. Sore throat, hoarseness, laryngospasm, bronchospasm are the main complications. Read more about this study

Who is it for?
Ages 2 to 18 years
What is being tested?
Lidocaine 10% Spray and Mometasone nasal spray
Could I receive a placebo?
No, everyone receives an active treatment
How many people
91 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Nov 2019to 15 Jun 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Being ages between 2 and 18
  • undergoing elective surgery
  • intubated patients over 1 hour
  • ASA(American Society of Anesthesiologists) Class I-II patients

Who cannot join

  • Urgent surgeries
  • Tonsillectomies, adenoidectomies ..etc, operations that causes sore throat due to the operation area.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Health and Science University Derince Training and Research Hospital

    Derince, Kocaeli, 41900

Other trials in Turkey (Türkiye)

About this study

Official title: A Comparison Between Local Anesthetics and Topical Cortikosteroids That is Applied to the Area of Cuff of Tracheal Intubation Tube in Pediatric Patients

This study aims to compare effects of two different agents on complications due to tracheal tube cuff in pediatric patients. Sore throat, hoarseness, laryngospasm, bronchospasm are the main complications.

Read the detailed description

In the literature there were studies about both local anesthetic agents and topical steroids and different densities of saline which were applied to decrease airway complications. In this study researchers intended to compare effects of local anesthetic agents and topical steroids applying around tracheal tube on airway complications which may occur in the first 24 hours after surgery. All pediatric patients scheduled for elective surgery will be recruited. enrolled patients will randomly assigned in to three groups: Control group, local anesthetic group and topical steroid group.

Being tested
Lidocaine 10% Spray, Mometasone nasal spray
Keywords
intubation, anesthesia, corticosteroids, lidocaine, complication of intubation
Medical subject headings
Pharyngitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lidocaine 10% SprayDrug

    Also called lidocaine

    lidocaine will be apply on the cuff

  • Mometasone nasal sprayDrug

    Also called steroid

    mometasone spray will be applied on the cuff

Study groups in NCT04085744
Study groupRoleWhat they receive
control groupNo interventionIn this group any drug will be applied on the cuff of the intubation tube
lidocaine groupActive comparator10% lidocaine spray will be applied on the cuff of the intubation tube topically and patient will be intubated.
Receives: Drug: Lidocaine 10% Spray
steroid groupActive comparatormometasone furoate spray will be applied on the cuff of the intubation tube topically and patient will be intubated.
Receives: Drug: Mometasone nasal spray

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual analog scale (VAS) for pain

    Self Reported VAS at postoperative unit. VAS 0 is no pain VAS 10 is pain as bad as can be

    Measured: 1 hour

  2. Visual analog scale (VAS) for pain

    Self reported VAS postoperative at hour 6. VAS 0 is no pain VAS 10 is pain as bad as can be

    Measured: 6 hours

  3. Visual analog scale (VAS) for pain

    Self reported VAS postoperative at hour 12. VAS 0 is no pain VAS 10 is pain as bad as can be

    Measured: 12 hours

  4. Visual analog scale (VAS) for pain

    Self reported VAS at postoperative hour 24. VAS 0 is no pain VAS 10 is pain as bad as can be

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Sep 2019
  2. Study start1 Nov 2019
  3. Primary completion15 Jun 2020
  4. Study completion15 Jun 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
91 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04085744
Sponsor's protocol ID
AOLC-1
Acronym
LA-STEROID
Status last verified
Nov 2023
First submitted
7 Sep 2019
Last updated
18 Nov 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Lidocaine 10% Spray and Mometasone nasal spray in people with Anesthesia Intubation Complication and Intubation Complication, run by Derince Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual analog scale (VAS) for pain (time frame: 1 hour). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in